How Can We Help?

< All Topics
You are here:
Print

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

Posted
Updated
Byecho_wpbaycrest_admin

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

Previous Long-term Risk of Dementia in Persons With Schizophrenia- A Danish Population-Based Cohort Study
Next Prevalence and Incidence Studies of Schizophrenic Disorders- A Systematic Review of the Literature
Table of Contents